Literature DB >> 18303561

Successful intraoperative spinal cord monitoring during scoliosis surgery using a total intravenous anesthetic regimen including dexmedetomidine.

David J Anschel1, Andrew Aherne, Roy G Soto, Wesley Carrion, Carl Hoegerl, Palgun Nori, Peggy A Seidman.   

Abstract

Intraoperative neurophysiological monitoring (IONM) during corrective spinal surgery is widely used. Because of the possible interference with the recording of evoked potentials by inhalational anesthetics, total intravenous anesthetic (TIVA) regimens have been advocated. TIVA regimens may be difficult to use in pediatric populations due to metabolic factors. We report on the results of multimodality IONM during 18 cases in which a TIVA regimen incorporating dexmedetomidine (Precedex, Hespira, Lake Forest, IL) was used. Monitoring techniques included sensory (SSEP) and motor evoked potentials (MEP), as well as pedicle screw stimulation. SSEPs were maintained within an acceptable range of baseline amplitude (50%) and latency (10%), and MEPs remained elicitable throughout each case. We therefore found that the anesthetic regimen did not significantly interfere with any of the monitoring modalities used and conclude that IONM in the presence of dexmedetomidine is feasible under appropriate conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18303561     DOI: 10.1097/WNP.0b013e318163cca6

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  9 in total

1.  Effects of different etomidate doses on intraoperative somatosensory-evoked potential monitoring.

Authors:  X-L Meng; L-W Wang; W Zhao; X-Y Guo
Journal:  Ir J Med Sci       Date:  2014-07-25       Impact factor: 1.568

2.  Preoperative pregabalin has no effect on intraoperative neurophysiological monitoring in adolescents undergoing posterior spinal fusion for spinal deformities: a double-blind, randomized, placebo-controlled clinical trial.

Authors:  Linda Helenius; Antti Puhakka; Tuula Manner; Olli Pajulo; Ilkka Helenius
Journal:  Eur Spine J       Date:  2017-11-17       Impact factor: 3.134

Review 3.  [Intraoperative electrophysiological monitoring with evoked potentials].

Authors:  R Nitzschke; N Hansen-Algenstaedt; J Regelsberger; A E Goetz; M S Goepfert
Journal:  Anaesthesist       Date:  2012-04       Impact factor: 1.041

4.  Evaluation of the Effect of Continuous Infusion of Dexmedetomidine or a Subanesthetic Dose Ketamine on Transcranial Electrical Motor Evoked Potentials in Adult Patients Undergoing Elective Spine Surgery under Total Intravenous Anesthesia: A Randomized Controlled Exploratory Study.

Authors:  Roshan Andleeb; Sanjay Agrawal; Priyanka Gupta
Journal:  Asian Spine J       Date:  2021-08-20

Review 5.  Anesthesia and intraoperative neurophysiological monitoring in children.

Authors:  Tod Sloan
Journal:  Childs Nerv Syst       Date:  2009-11-04       Impact factor: 1.475

6.  Anesthetic considerations in acute spinal cord trauma.

Authors:  Neil Dooney; Armagan Dagal
Journal:  Int J Crit Illn Inj Sci       Date:  2011-01

7.  Effects of Dexmedetomidine on motor- and somatosensory-evoked potentials in patients with thoracic spinal cord tumor: a randomized controlled trial.

Authors:  Yan Li; Lingzhong Meng; Yuming Peng; Hui Qiao; Lanjun Guo; Ruquan Han; Adrian W Gelb
Journal:  BMC Anesthesiol       Date:  2016-08-02       Impact factor: 2.217

8.  Comparison of the Effect of Ketamine and Dexmedetomidine Combined with Total Intravenous Anesthesia in Laparoscopic Cholecystectomy Procedures: A Prospective Randomized Controlled Study.

Authors:  E Efe Mercanoglu; N Girgin Kelebek; G Turker; H Aksu; M Ozgur; Z Karakuzu; S Turkcan; B Ozcan
Journal:  Int J Clin Pract       Date:  2022-07-21       Impact factor: 3.149

9.  Effect of dexmedetomidine-etomidate-fentanyl combined anesthesia on somatosensory- and motor-evoked potentials in patients undergoing spinal surgery.

Authors:  Sheng Lin; Na Dai; Zhengyan Cheng; Wei Shao; Zhijian Fu
Journal:  Exp Ther Med       Date:  2014-02-18       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.